ReFlow Therapeutics becomes CorFlow Therapeuticsadmin
ReFlow Therapeutics becomes CorFlow Therapeutics
Baar, Switzerland, May 10th 2017
ReFlow Therapeutics AG today announced that the Company has changed name to CorFlow Therapeutics AG.
The name change is made to avoid any confusion with the already existing ReFlow Medical, Inc.
The new home page of CorFlow, www.corflow-therapeutics.ch, is active and our email addresses have changed using the extension @corflow-therapeutics.ch.
We look forward meeting you during the upcoming EuroPCR conference in Paris.
CorFlow at EuroPCR17
CorFlow will attend the upcoming EuroPCR meeting in Paris between May 15th and 18th. EuroPCR is one of the world-leading conferences in interventional cardio-vascular medicine. The CorFlow management team looks forward to meet our Key Opinion Leaders, investors, corporates and suppliers in Paris.
CorFlow Therapeutics AG (www.corflow-therapeutics.ch) is developing proprietary technologies for diagnosis and treatment of microvascular obstructions (MVO). The technologies will enable interventional cardiologists to diagnose and treat severe heart attack patients with MVO thereby potentially reducing the short- and long-term complication rates including heart failure.